Approval · Notice of Compliance 37364 · 2026
ELFY: Notice of Compliance 37364
Issued April 20, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37364
- Date
- April 20, 2026
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- LOLO (Allergan Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ELFY | 02553481 | Marketed |
Medicinal ingredients
- ETHINYL ESTRADIOL 0.01 MG per TAB
- NORETHINDRONE ACETATE 1 MG per TAB